A current understanding of drug-induced QT prolongation and its implications for anticancer therapy.

Roden DM
Cardiovasc Res. 2019 115 (5): 895-903

PMID: 30689740 · PMCID: PMC7967705 · DOI:10.1093/cvr/cvz013

MeSH Terms (13)

Action Potentials Animals Antineoplastic Agents Genetic Predisposition to Disease Heart Conduction System Heart Rate Humans Long QT Syndrome Membrane Transport Proteins Molecular Targeted Therapy Prognosis Risk Assessment Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: